Zephyr Valve Japan Post-Marketing Surveillance — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Zephyr Valve Japan Post-Marketing Surveillance — Stella

Recruiting

Back to Emphysema trials

Trial locations(17 sites)

Japan

Tosei General Hospital, Aichi

Gifu Prefectural Medical Center, Gifu

Kanagawa Cardio Chest Center, Kanagawa

Kanazawa University Hospital, Kanazawa

St Marianna University Hospital, Kawasaki

Key details

Sponsor

Pulmonx Corporation

Enrollment target

~140 participants

Started

March 2024

Primary completion

March 2027

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov